{
  "content": "Table 3 presents changes in quality-of-life scores and exercise capacity from baseline to one year of follow-up for patients remaining in sinus rhythm and those with persistent atrial fibrillation. Scores for physical functioning, general health, and social functioning on the SF-36 were significantly better in the group in sinus rhythm than in the group with persistent atrial fibrillation, and there was a trend toward an improvement in vitality scores in the former group (P=0.08). The differences in scores for physical-role limitations, pain, emotional-role limitations, and mental health between the two groups were not significant",
  "source": "https://www.nejm.org/doi/full/10.1056/NEJMoa041705",
  "chunk_id": "d26369f5-f5d9-4c93-81b6-8b1e24ad4577",
  "similarity_score": 0.31760936975479126,
  "query": "amiodarone beta-blockers quality of life functional capacity exercise tolerance atrial fibrillation patient reported outcomes",
  "rank": 28,
  "title": "Amiodarone versus Sotalol for Atrial Fibrillation",
  "authors": "Bramah N. Singh, M.D., D.Sc., Steven N. Singh, M.D., Domenic J. Reda, Ph.D., X. Charlene Tang, M.D., Ph.D., Becky Lopez, R.N., Crystal L. Harris, Pharm.D., Ross D. Fletcher, M.D., Satish C. Sharma, M.D., J. Edwin Atwood, M.D., Alan K. Jacobson, M.D., H. Daniel Lewis, Jr., M.D., Dennis W. Raisch, Ph.D., Michael D. Ezekowitz, M.B., Ch.B., Ph.D.",
  "year": "2005",
  "journal": "New England Journal of Medicine",
  "reference": "Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D. Jr., Raisch, D. W., & Ezekowitz, M. D. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352(18), 1861-1872. https://doi.org/10.1056/NEJMoa041705",
  "doi": "10.1056/NEJMoa041705",
  "chunk_index": 37,
  "total_chunks": 127,
  "retrieved_at": "2025-07-24T21:58:02.962289"
}